Literature DB >> 19143745

Automated QT analysis that learns from cardiologist annotations.

Iain Guy David Strachan1, Nicholas Peter Hughes, Mustafa Hashim Poonawala, Jay W Mason, Lionel Tarassenko.   

Abstract

BACKGROUND: Reliable, automated QT analysis would allow the use of all the ECG data recorded during continuous Holter monitoring, rather than just intermittent 10-second ECGs.
METHODS: BioQT is an automated ECG analysis system based on a Hidden Markov Model, which is trained to segment ECG signals using a database of thousands of annotated waveforms. Each sample of the ECG signal is encoded by its wavelet transform coefficients. BioQT also produces a confidence measure which can be used to identify unreliable segmentations. The automatic generation of templates based on shape descriptors allows an entire 24 hours of QT data to be rapidly reviewed by a human expert, after which the template annotations can automatically be applied to all beats in the recording.
RESULTS: The BioQT software has been used to show that drug-related perturbation of the T wave is greater in subjects receiving sotalol than in those receiving moxifloxacin. Chronological dissociation of T-wave morphology changes from the QT prolonging effect of the drug was observed with sotalol. In a definitive QT study, the percentage increase of standard deviation of QT(c) for the standard manual method with respect to that obtained with BioQT analysis was shown to be 44% and 30% for the placebo and moxifloxacin treatments, respectively.
CONCLUSIONS: BioQT provides fully automated analysis, with confidence values for self-checking, on very large data sets such as Holter recordings. Automatic templating and expert reannotation of a small number of templates lead to a reduction in the sample size requirements for definitive QT studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19143745      PMCID: PMC6932077          DOI: 10.1111/j.1542-474X.2008.00259.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  5 in total

1.  International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.

Authors: 
Journal:  Fed Regist       Date:  2005-10-20

2.  Algorithms for computerized QT analysis.

Authors:  Q Xue; S Reddy
Journal:  J Electrocardiol       Date:  1998       Impact factor: 1.438

3.  Automatic detection of wave boundaries in multilead ECG signals: validation with the CSE database.

Authors:  P Laguna; R Jané; P Caminal
Journal:  Comput Biomed Res       Date:  1994-02

Review 4.  Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias.

Authors:  Robert S Kass; Arthur J Moss
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

5.  Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods.

Authors:  Nenad Sarapa; Joel Morganroth; Jean-Philippe Couderc; Steven F Francom; Borje Darpo; Joseph C Fleishaker; Janet D McEnroe; William T Chen; Wojciech Zareba; Arthur J Moss
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-01       Impact factor: 1.468

  5 in total
  2 in total

Review 1.  The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance.

Authors:  Borje Darpo
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

2.  Highly automated QT measurement techniques in 7 thorough QT studies implemented under ICH E14 guidelines.

Authors:  Jean-Philippe Couderc; Christine Garnett; Mike Li; Robert Handzel; Scott McNitt; Xiajuan Xia; Slava Polonsky; Wojciech Zareba
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-01       Impact factor: 1.468

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.